Awad Mark, Schaper Nicholas, Bose Saideep, Smeds Matthew R
Saint Louis University Division of Vascular and Endovascular Surgery, St. Louis, MO.
Saint Louis University School of Medicine, St. Louis, MO.
J Vasc Surg Cases Innov Tech. 2024 Jun 21;10(5):101554. doi: 10.1016/j.jvscit.2024.101554. eCollection 2024 Oct.
Chronic venous insufficiency (CVI) is increasing in prevalence on a global scale. Current treatment options are limited to improving venous return, ablation of refluxing veins, and reducing outflow obstruction. A new bioprosthetic device, the VenoValve, may bridge the gap of treatment for patients with chronic venous insufficiency who have failed prior treatment. We demonstrate the treatment of a 72-year-old man with bilateral venous insufficiency and leg wounds using this device in his left femoral vein via an open anterior surgical approach. The patient had no postoperative complications, and a patent valve at 6 months. The VenoValve may be a viable option for patients with advanced chronic venous insufficiency.
慢性静脉功能不全（CVI）在全球范围内的患病率正在上升。目前的治疗选择仅限于改善静脉回流、消融反流静脉以及减少流出道梗阻。一种新型生物假体装置——静脉瓣膜（VenoValve），可能为先前治疗失败的慢性静脉功能不全患者填补治疗空白。我们展示了通过开放前路手术方法，在一名72岁双侧静脉功能不全且腿部有伤口的男性患者的左股静脉中使用该装置进行治疗的过程。该患者术后无并发症，6个月时瓣膜功能良好。对于晚期慢性静脉功能不全患者，静脉瓣膜可能是一种可行的选择。
